Acinetobacter baumannii is a multidrug resistant emergent pathogen responsible for nosocomial infections. The anticancer drug mitomycin C (MMC) is able to kill A. baumannii exponential-phase, stationary-phase and biofilm cells. MMC rescues Galleria mellonella against lethal doses of reference and clinical multidrug resistant A. baumannii strains.